Targeted therapy against VEGFR and EGFR signaling with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic mouse model of human non-small cell lung cancer

被引：0
|
作者：
Shibuya, K
Komaki, R
Wu, W
Shintani, T
Itasaka, S
Isobe, T
Ryan, A
Herbst, RS
O'Reilly, MS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] AstraZeneca, Macclesfield, Cheshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
35
引用
收藏
页码：S149 / S150
页数：2
相关论文
共 50 条
  • [1] Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer
    Shibuya, Keiko
    Komaki, Ritsuko
    Shintani, Tomoaki
    Itasaka, Satoshi
    Ryan, Anderson
    Jurgensmeier, Juliane M.
    Milas, Luka
    Ang, Kian
    Herbst, Roy S.
    O'Reilly, Michael S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05): : 1534 - 1543
  • [2] Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in tumor-bearing nude mice
    Ma, H.
    Gleditsch, E.
    Kuehne, M.
    Ruebe, C.
    Ruebe, C. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 78 - 78
  • [3] Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells
    Siddik Sarkar
    Shashi Rajput
    Amit Kumar Tripathi
    Mahitosh Mandal
    Molecular Cancer, 12
  • [4] Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells
    Sarkar, Siddik
    Rajput, Shashi
    Tripathi, Amit Kumar
    Mandal, Mahitosh
    MOLECULAR CANCER, 2013, 12
  • [5] Clinical trials of antiangiogenic therapy in non-small cell lung cancer: focus on bevacizumab and ZD6474
    Morgensztern, Daniel
    Govindan, Ramaswamy
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (04) : 545 - 551
  • [6] Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
    Flanigan, Jaclyn
    Deshpande, Hari
    Gettinger, Scott
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 237 - 243
  • [7] Targeted therapy against VEGF and EGF receptor signaling with ZD6474 blocks angiogenesis and inhibits the growth and dissemination of orthotopic human lung cancer in mice.
    Wu, WJ
    Isobe, T
    Oon, A
    Shintani, T
    Itasaka, S
    Shibuya, K
    Langley, RR
    Hansen, JC
    Fidler, IJ
    Ryan, AJ
    Herbst, RS
    O'Reilly, MS
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6143S - 6143S
  • [8] Antitumor efficacy of ZD6474, a VEGFR tyrosine kinase signaling inhibitor with additional activity against EGFR tyrosine kinase, alone and in combination with radiotherapy in human head and neck cancer
    Raben, D
    Gustafson, DL
    Frederick, B
    Merz, AL
    Zirrolli, JA
    LUNG CANCER, 2004, 46 : S24 - S25
  • [9] Enhanced sensitivity of tumor cells to the EGFR/VEGFR inhibitor ZD6474 by FUS1 and FHIT-nanoparticle-mediated gene therapy in human lung cancer
    Sakai, Ryo
    Jayachandran, Gitanjali
    Fang, Bingliang
    Roth, Jack
    Ji, Lin
    CANCER RESEARCH, 2009, 69
  • [10] Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies
    Lim, Sun Min
    Syn, Nicholas L.
    Cho, Byoung Chul
    Soo, Ross A.
    CANCER TREATMENT REVIEWS, 2018, 65 : 1 - 10
12345